BindingDB PrimarySearch

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350042(US10208024, Example 41 | US10766881, Example 41)

IC50: 0.800nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350051(US10208024, Example 50 | US10766881, Example 50)

IC50: 0.900nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350049(6-(3-amino-6-(1-methyl- 1H-pyrazol-4-yl)pyrazin- 2...)

IC50: 1nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350082(US10208024, Example 81 | US10766881, Example 81)

IC50: 1.10nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350033(US10208024, Example 32 | US10766881, Example 32)

IC50: 1.30nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350050(6-(3-amino-6-(1-methyl- 1H-pyrazol-4-yl)pyrazin- 2...)

IC50: 1.30nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350045(US10208024, Example 44 | US10766881, Example 44)

IC50: 1.40nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350043(US10208024, Example 42 | US10766881, Example 42)

IC50: 1.40nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350032(US10208024, Example 31 | US10766881, Example 31)

IC50: 1.40nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM462139(US10766881, Example 60)

IC50: 1.5nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350048(US10208024, Example 47 | US10766881, Example 47)

IC50: 1.60nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350015(6-(3-amino-6-(1- methyl-1H-pyrazol-4- yl)pyrazin-2...)

IC50: 1.60nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350044(US10208024, Example 43 | US10766881, Example 43)

IC50: 1.60nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350034(US10208024, Example 33 | US10766881, Example 33)

IC50: 1.80nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350025(US10208024, Example 24 | US10766881, Example 24)

IC50: 1.80nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350028(US10208024, Example 27 | US10766881, Example 27)

IC50: 1.90nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350027(US10208024, Example 26 | US10766881, Example 26)

IC50: 2.20nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350029(US10208024, Example 28 | US10766881, Example 28)

IC50: 2.30nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350059(US10208024, Example 58 | US10766881, Example 58)

IC50: 2.40nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350020(US10208024, Example 19 | US10766881, Example 19)

IC50: 2.80nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350005(1-((4-(5-amino-6-(1- (3,5- dimethoxyphenyl)-6- oxo...)

IC50: 2.80nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350031(US10208024, Example 30 | US10766881, Example 30)

IC50: 2.90nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350041(US10208024, Example 40 | US10766881, Example 40)

IC50: 2.90nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350066(US10208024, Example 65 | US10766881, Example 65)

IC50: 2.90nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350083(US10208024, Example 82 | US10766881, Example 82)

IC50: 3.10nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350006(6-(3-amino-6-(1- (4,4,4-trifluoro-2- hydroxybutyl)...)

IC50: 3.20nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350036(US10208024, Example 35 | US10766881, Example 35)

IC50: 3.20nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350002(US10208024, Example 1 | US10766881, Example 1)

IC50: 3.40nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350079(US10208024, Example 78 | US10766881, Example 78)

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350030(US10208024, Example 29 | US10766881, Example 29)

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350035(US10208024, Example 34 | US10766881, Example 34)

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350016(6-(3-amino-6-(1- isopropyl-1H-pyrazol- 4-yl)pyrazi...)

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350077(US10208024, Example 76 | US10766881, Example 76)

IC50: 3.85nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350053(US10208024, Example 52 | US10766881, Example 52)

IC50: 5nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350024(US10208024, Example 23 | US10766881, Example 23)

IC50: 5.5nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350017(6-(3-amino-6-(1- (pentan-3-yl)-1H- pyrazol-4-yl)py...)

IC50: 5.60nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350058(US10208024, Example 57 | US10766881, Example 57)

IC50: 5.80nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350037(US10208024, Example 36 | US10766881, Example 36)

IC50: 6.20nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350078(US10208024, Example 77 | US10766881, Example 77)

IC50: 6.20nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350080(US10208024, Example 79 | US10766881, Example 79)

IC50: 6.30nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350056(US10208024, Example 55 | US10766881, Example 55)

IC50: 6.30nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350007(2-(4-(5-amino-6-(1- (3,5- dimethoxyphenyl)-6- oxo-...)

IC50: 6.40nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350068(US10208024, Example 67 | US10766881, Example 67)

IC50: 6.5nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350008(6-(3-amino-6-(1-(1- hydroxy-2- methylpropan-2-yl)-...)

IC50: 6.5nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350026(US10208024, Example 25 | US10766881, Example 25)

IC50: 6.60nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350060(US10208024, Example 59 | US10766881, Example 59)

IC50: 6.60nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350022(6-(3-amino-6-(1- isobutyl-1H-pyrazol- 4-yl)pyrazin...)

IC50: 7.5nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350057(US10208024, Example 56 | US10766881, Example 56)

IC50: 7.5nMMore data for this Ligand-Target Pair

Fibroblast growth factor receptor 2 [403-822](Homo sapiens (Human))
Array Biopharma

US Patent

BDBM350067(US10208024, Example 66 | US10766881, Example 66)

IC50: 7.80nMMore data for this Ligand-Target Pair